In TRIUMPH-4, a 68 week trial in adults with obesity or overweight plus knee osteoarthritis, the 12 mg arm averaged 28.7% body weight loss using the efficacy estimand, with the 9 mg arm at 26.4%
Moreover, QCN has been reported to effective in the management of multiple sclerosis (MS) and other demyelinating diseases (Javanbakht et al
We also summarize current evidence on ferroptosis involvement in OA progression
It stimulates the pituitary gland to release growth hormone (GH), and GH itself has a mild, transient diabetogenic effect, meaning it can temporarily raise blood sugar and decrease insulin sensitivity
Its the same mechanism that makes you feel exhausted when youre fighting an infection, just at a lower, chronic level
J Neurol 270(2):851863 Wharton S et al (2022) Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss